These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 1517574)

  • 41. Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2.
    Khusmith S; Sedegah M; Hoffman SL
    Infect Immun; 1994 Jul; 62(7):2979-83. PubMed ID: 8005684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.
    Charoenvit Y; Majam VF; Corradin G; Sacci JB; Wang R; Doolan DL; Jones TR; Abot E; Patarroyo ME; Guzman F; Hoffman SL
    Infect Immun; 1999 Nov; 67(11):5604-14. PubMed ID: 10531206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii.
    Reed RC; Louis-Wileman V; Cosmai EV; Fang S; Jue DL; Wohlhueter RM; Hunter RL; Lal AA
    Vaccine; 1997 Apr; 15(5):482-8. PubMed ID: 9160515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rhop-3 protein conservation among Plasmodium species and induced protection against lethal P. yoelii and P. berghei challenge.
    Wang T; Fujioka H; Drazba JA; Sam-Yellowe TY
    Parasitol Res; 2006 Aug; 99(3):238-52. PubMed ID: 16541261
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A small peptide (CEL-1000) derived from the beta-chain of the human major histocompatibility complex class II molecule induces complete protection against malaria in an antigen-independent manner.
    Charoenvit Y; Brice GT; Bacon D; Majam V; Williams J; Abot E; Ganeshan H; Sedegah M; Doolan DL; Carucci DJ; Zimmerman DH
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2455-63. PubMed ID: 15215094
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of the merozoite surface protein 4/5 gene of Plasmodium berghei and Plasmodium yoelii.
    Kedzierski L; Black CG; Coppel RL
    Mol Biochem Parasitol; 2000 Jan; 105(1):137-47. PubMed ID: 10613706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasmodium-host interactions directly influence the threshold of memory CD8 T cells required for protective immunity.
    Schmidt NW; Butler NS; Harty JT
    J Immunol; 2011 May; 186(10):5873-84. PubMed ID: 21460205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites.
    Sedegah M; Weiss WW; Hoffman SL
    Parasite Immunol; 2007 Nov; 29(11):559-65. PubMed ID: 17944745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain.
    Goschnick MW; Black CG; Kedzierski L; Holder AA; Coppel RL
    Infect Immun; 2004 Oct; 72(10):5840-9. PubMed ID: 15385485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A subdominant CD8(+) cytotoxic T lymphocyte (CTL) epitope from the Plasmodium yoelii circumsporozoite protein induces CTLs that eliminate infected hepatocytes from culture.
    Franke ED; Sette A; Sacci J; Southwood S; Corradin G; Hoffman SL
    Infect Immun; 2000 Jun; 68(6):3403-11. PubMed ID: 10816491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites.
    Mauduit M; Grüner AC; Tewari R; Depinay N; Kayibanda M; Chavatte JM; Franetich JF; Crisanti A; Mazier D; Snounou G; Rénia L
    PLoS One; 2009 Nov; 4(11):e7717. PubMed ID: 19890387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distinct T cell specificities are induced with the authentic versus recombinant Plasmodium berghei circumsporozoite protein.
    Krzych U; Jareed T; Link HT; Loomis LD; Ballou WR
    J Immunol; 1992 Apr; 148(8):2530-8. PubMed ID: 1348519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunological studies in rodent malaria. I: Protective immunity induced in mice by mild strains of Plasmodium berghei yoelii against a virulent and fatal line of this plasmodium.
    Hargreaves J; Yoeli M; Nussenzweig RS
    Ann Trop Med Parasitol; 1975 Sep; 69(3):289-99. PubMed ID: 1098589
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nematode-induced interference with the anti-Plasmodium CD8+ T-cell response can be overcome by optimizing antigen administration.
    Kolbaum J; Tartz S; Hartmann W; Helm S; Nagel A; Heussler V; Sebo P; Fleischer B; Jacobs T; Breloer M
    Eur J Immunol; 2012 Apr; 42(4):890-900. PubMed ID: 22161305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD8+ T-cell protective immunity induced by immunization with Plasmodium berghei CS protein-derived synthetic peptides: evidence that localization of peptide-specific CTLs is crucial for protection against malaria.
    Renggli J; Valmori D; Romero JF; Eberl G; Romero P; Betschart B; Corradin G
    Immunol Lett; 1995 May; 46(1-2):199-205. PubMed ID: 7590920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules.
    Rodrigues M; Nussenzweig RS; Romero P; Zavala F
    J Exp Med; 1992 Apr; 175(4):895-905. PubMed ID: 1372647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes.
    Weiss WR; Mellouk S; Houghten RA; Sedegah M; Kumar S; Good MF; Berzofsky JA; Miller LH; Hoffman SL
    J Exp Med; 1990 Mar; 171(3):763-73. PubMed ID: 1689762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge.
    Purcell LA; Wong KA; Yanow SK; Lee M; Spithill TW; Rodriguez A
    Vaccine; 2008 Sep; 26(38):4880-4. PubMed ID: 18672017
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Partial protection against malaria by immunization with Leishmania enriettii expressing the Plasmodium yoelii circumsporozoite protein.
    Wang HH; Rogers WO; Kang YH; Sedegah M; Hoffman SL
    Mol Biochem Parasitol; 1995 Feb; 69(2):139-48. PubMed ID: 7770079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites.
    Ak M; Bower JH; Hoffman SL; Sedegah M; Lees A; Carter M; Beaudoin RL; Charoenvit Y
    Infect Immun; 1993 Jun; 61(6):2493-7. PubMed ID: 8500885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.